FDA Panel Narrowly Backs COVID-19 Pill from Merck

Published on November 30, 2021

A panel of U.S. health advisers on Tuesday narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the virus. A Food and Drug Administration panel…

Read Full Article (External Site)